GlassScriptPhysician profile
Christina A Kozar
NPI 1528171824
$760.78
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $85.75 · 2021: $153 · 2022: $210 · 2023: $90.72 · 2024: $33.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $225.58 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $110.46 | 2019-2022 | |
| Sobi, INC | $60.62 | 2020-2022 | |
| Cranial Technologies, INC | $53.54 | 2021-2022 | |
| Sanofi Pasteur INC. | $51.77 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $51.45 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.76 | 2021 | |
| Pfizer INC. | $42.53 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $33.36 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Biogen, INC. | $21.75 | 2021 | |
| Medline Industries LP | $20.55 | 2019 | |
| Shire North American Group INC | $16.72 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.02 | 2019 | |
| Phadia US INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Kozar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.